Search for: "MERRELL v. U.S."
Results 21 - 40
of 354
Sorted by Relevance
|
Sort by Date
13 Feb 2020, 9:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), and thus should not have been admitted nor relied upon. [read post]
22 Jun 2010, 2:16 pm
Merrell Down Pharmaceuticals, Inc., 509 U.S. 579, 113 S. [read post]
25 Sep 2024, 11:37 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), in allowing testimony from EcoFactor's damages expert. [read post]
23 Mar 2009, 7:28 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
12 Jun 2017, 8:04 pm
Inc., 509 U.S. 579 (1973)) and satisfies the requirements of Comcast Corp. v. [read post]
8 Jul 2011, 8:52 am
Trial Ruling by the U.S. [read post]
1 Jul 2014, 11:24 am
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993) (interpreting the role of the judge under Rule 702 of the Federal Rules of Evidence, which is substantially similar to amended N.C. [read post]
27 Mar 2018, 11:35 am
Merrell Dow Pharm., Inc., 509 U.S. 579(1993). [read post]
20 Aug 2019, 6:21 am
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993), which set forth a new standard for admitting expert testimony. [read post]
23 Dec 2017, 10:36 am
Merrell Dow Pharm., Inc.). [read post]
22 May 2014, 10:51 am
Merrell Dow Pharm., Inc., 509 U.S. 579, 597 (1993). [read post]
16 Aug 2024, 5:55 am
Merrell Dow Pharma., Inc., 509 U.S. 579 (1993). [read post]
26 May 2015, 6:40 pm
Merrell Dow Pharms., 509 U.S. 579 (U.S. 1993). [read post]
28 May 2015, 2:29 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 593 (1993). [read post]
22 Jan 2023, 8:19 am
Merrell Dow Pharmaceuticals. [read post]
29 Jun 2020, 12:41 pm
Merrell Dow Pharmaceuticals Inc., 509 U.S. 579 (1993), and the testimony is helpful to the trier of fact to understand the evidence through specialized, scientific, or technical expertise. [read post]
1 Dec 2010, 11:02 am
U.S. ex rel. [read post]
18 Feb 2009, 12:01 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 589 (1993) Can the Daubert requirement be fulfilled during the trial? [read post]
12 Nov 2024, 6:18 pm
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993) in admitting testimony from EcoFactor's damages expert deriving a per-unit royalty rate from portfolio license agreements. [read post]
20 Jun 2010, 10:50 am
Only plaintiff's claim for injunctive reliefcan proceed.In Merrell v. [read post]
